Winton Capital »

Trevi Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0M 107k 18.65

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Solstice Advanced Matls Com Shs (SOLS)
Kla Corp Com New (KLAC)
Masco Corporation (MAS)
Cme (CME)
CSX Corporation (CSX)
Incyte Corporation (INCY)
Entegris (ENTG)
Crowdstrike Hldgs Cl A (CRWD)
Public Storage (PSA)
AES Corporation (AES)
Powell Industries (POWL)

View all positions for Winton Capital

Top funds holding Trevi Therapeutics

NEA Management Company
FMR
BlackRock
Frazier Life Sciences Management
Wellington Management Company
Vanguard Capital Management
Vivo Capital
Woodline Partners
Vestal Point Capital
MPM Oncology Impact Management
Frontier Capital Management
Geode Capital Management
Marshall Wace
State Street Corporation
Eventide Asset Management

View all funds holding Trevi Therapeutics